Atlas Trials

A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder

Clinical trial NCT01357993 · COMPLETED

Trial details

NCT number
NCT01357993
Sponsor
Janssen Pharmaceutical K.K.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention-Deficit / Hyperactivity Disorder
Start date
2011-05-01
Primary completion
2013-03-01
Enrollment
253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.